SCHEMBL14083069

SCHEMBL14083069

COc1ccc(NC(=O)c2ccc(-c3ncccc3C(F)(F)F)c(OC)c2)cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TRPV1 Q8NER1 6/20 0.60
▸ GRM4 Q14833 1/20 0.56
▸ MALT1 Q9UDY8 1/20 0.54
▸ SMN1; SMN2 Q16637 6/20 0.54
▸ NPC1 O15118 4/20 0.54
▸ RAB9A P51151 4/20 0.54
▸ MAPT P10636 7/20 0.53
▸ LMNA P02545 1/20 0.53
▸ GAA P10253 1/20 0.53
▸ MEN1 O00255 5/20 0.52
▸ KMT2A Q03164 5/20 0.52
▸ KDM4E B2RXH2 3/20 0.52
▸ THRB P10828 2/20 0.52
▸ HPGD P15428 1/20 0.52
▸ TP53 P04637 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.50
▸ RORC P51449 1/20 0.50
▸ GLA P06280 1/20 0.50
▸ CYP2D6 P10635 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083255 0.95 TRPV1 (0.59) TRPV1GRM4MALT1SMN1; SMN2NPC1
SCHEMBL14084098 0.94 TRPV1 (0.57) TRPV1GRM4MALT1SMN1; SMN2NPC1
SCHEMBL14083071 0.92 MAPT (0.63) TRPV1GRM4RAB9AMAPTLMNA
SCHEMBL14083086 0.91 TRPV1 (0.63) TRPV1SMN1; SMN2MAPTLMNAGAA
SCHEMBL14083068 0.90 TRPV1 (0.64) TRPV1MAPTLMNAGAA
SCHEMBL14083295 0.90 TRPV1 (0.59) TRPV1GRM4MALT1SMN1; SMN2RAB9A
SCHEMBL14084053 0.89 TRPV1 (0.66) TRPV1GRM4MALT1SMN1; SMN2NPC1
SCHEMBL14083849 0.89 MAPT (0.55) TRPV1GRM4MALT1SMN1; SMN2RAB9A
SCHEMBL14083082 0.89 TRPV1 (0.57) TRPV1RAB9AMAPTLMNAGAA
SCHEMBL14083757 0.88 GRM4 (0.63) TRPV1GRM4MALT1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 TRPV1 1/4885GRM4 362/4885MALT1 3991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback